[go: up one dir, main page]

BE899000A - Compositions a base de diltiazem pour la prophylaxie et le traitement des arterioscleroses - Google Patents

Compositions a base de diltiazem pour la prophylaxie et le traitement des arterioscleroses

Info

Publication number
BE899000A
BE899000A BE0/212448A BE212448A BE899000A BE 899000 A BE899000 A BE 899000A BE 0/212448 A BE0/212448 A BE 0/212448A BE 212448 A BE212448 A BE 212448A BE 899000 A BE899000 A BE 899000A
Authority
BE
Belgium
Prior art keywords
arteriosclerosis
prophylaxis
treatment
diltiazem
compositions
Prior art date
Application number
BE0/212448A
Other languages
English (en)
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of BE899000A publication Critical patent/BE899000A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

L'invention concerne une composition pharmaceutique destinée à la prophylaxie et au traitement de l'artériosclérose, comme l'athérosclérose, la sclérose de Monkeberg et l'artériolosclérose, caractérisée en ce qu'elle comprend, à titre d'ingrédient actif, du diltiazem ou un sel d'addition d'un acide pharmaceutiquement acceptable de ce composé, ainsi qu'un procédé de prophylaxie et de traitement de l'artériosclérose précitée par l'administration du diltiazem ou d'un sel de ce composé à un patient.
BE0/212448A 1983-02-25 1984-02-24 Compositions a base de diltiazem pour la prophylaxie et le traitement des arterioscleroses BE899000A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58031515A JPS59157021A (ja) 1983-02-25 1983-02-25 動脈硬化症予防治療剤

Publications (1)

Publication Number Publication Date
BE899000A true BE899000A (fr) 1984-06-18

Family

ID=12333337

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212448A BE899000A (fr) 1983-02-25 1984-02-24 Compositions a base de diltiazem pour la prophylaxie et le traitement des arterioscleroses

Country Status (12)

Country Link
JP (1) JPS59157021A (fr)
BE (1) BE899000A (fr)
CH (1) CH658389A5 (fr)
DE (1) DE3406837A1 (fr)
DK (1) DK163712C (fr)
FR (1) FR2541577B1 (fr)
GB (1) GB2135192B (fr)
HK (1) HK45389A (fr)
IT (1) IT1178863B (fr)
NL (1) NL8400548A (fr)
SE (1) SE8400971L (fr)
SG (1) SG21189G (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
JPS63107925A (ja) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd 動脈硬化症予防・治療剤
JP2658783B2 (ja) * 1992-12-10 1997-09-30 田辺製薬株式会社 抗動脈硬化剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1236467A (en) * 1967-10-28 1971-06-23 Tanabe Seiyaku Co Benzothiazepine derivatives
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives

Also Published As

Publication number Publication date
DE3406837C2 (fr) 1990-12-20
GB8405060D0 (en) 1984-04-04
DK163712C (da) 1992-08-31
DK103084A (da) 1984-08-26
DE3406837A1 (de) 1984-08-30
HK45389A (en) 1989-06-16
SG21189G (en) 1990-01-26
IT8467183A1 (it) 1985-08-24
FR2541577B1 (fr) 1987-05-22
IT8467183A0 (it) 1984-02-24
JPS59157021A (ja) 1984-09-06
IT1178863B (it) 1987-09-16
GB2135192B (en) 1986-10-22
SE8400971L (sv) 1984-08-26
JPS6358809B2 (fr) 1988-11-17
DK163712B (da) 1992-03-30
SE8400971D0 (sv) 1984-02-22
DK103084D0 (da) 1984-02-24
NL8400548A (nl) 1984-09-17
FR2541577A1 (fr) 1984-08-31
CH658389A5 (de) 1986-11-14
GB2135192A (en) 1984-08-30

Similar Documents

Publication Publication Date Title
AU6767587A (en) Pharmaceutical compositions
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
BE901737A (fr) Composition pharmaceutique pour le traitement de l'ischemie myocardique aigue.
FI935847A (fi) L-DOPA-esterikoostumukset
CA2191129A1 (fr) Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine
RU94046137A (ru) Фосфонсульфонатные соединения для лечения аномального кальциевого и фосфатного обмена, фармацевтическая композиция
FI945599A0 (fi) Fosfonokarboksylaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
ES8504682A1 (es) Un procedimiento para la preparacion de compuestos nitro alifaticos
BE1002239A5 (fr) Solution pharmaceutique.
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
BE899000A (fr) Compositions a base de diltiazem pour la prophylaxie et le traitement des arterioscleroses
CA2136825A1 (fr) Composes phosphonate a ammonium quaternaire pour le traitement du metabolisme anormal du calcium et du phosphate, ainsi que du tartre dentaire
MA24670A1 (fr) Methode pour la preparation d'acides 4-phenyl-4-cyano-cyclohexanoiques substitues
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
MA26744A1 (fr) Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant
MA27157A1 (fr) Methode de traitement d'affections osseuses.
CA2136823A1 (fr) Composes phosphonosulfonate pour le traitement du metabolisme anormal du calcium et du phosphate
FR2433943A1 (fr) Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie
BE901879A (fr) Produits analogues de la 1alpha-hydroxyvitamine d2, leur procede de preparation et compositions pharmaceutiques les renfermant.
US4663345A (en) Etodolac for treatment of gout
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
RU94046103A (ru) Содержащие четвертичный азот фосфонатные соединения для лечения аномального кальциевого и фосфатного метаболизма, фармацевтическая композиция, способ лечения

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: TANABE SEIYAKU CO. LTD

Effective date: 19990228